Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PC-A11 with superficial and interstitial laser light in recurrent head and neck squamous cell carcinoma
2011-003751-19Phase 2Terminated
- Sponsor
- PCI Biotech
- Start
- Nov 2011
- Modality
- Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fimaporfin in head and neck squamous cell carcinoma (HNSCC), head and neck cancer (HNC), sponsored by PCI Biotech. Started Nov 2011; status: terminated.
02
Drugs
fimaporfin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)head and neck cancer (HNC)
Beyond the preview
Go deeper on 2011-003751-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003751-19.